NO871574D0 - Fremgangsmaate for fremstilling av terapeutisk aktive peptider. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive peptider.

Info

Publication number
NO871574D0
NO871574D0 NO871574A NO871574A NO871574D0 NO 871574 D0 NO871574 D0 NO 871574D0 NO 871574 A NO871574 A NO 871574A NO 871574 A NO871574 A NO 871574A NO 871574 D0 NO871574 D0 NO 871574D0
Authority
NO
Norway
Prior art keywords
lys
leu
arg
preparation
procedure
Prior art date
Application number
NO871574A
Other languages
English (en)
Other versions
NO871574L (no
Inventor
Osamu Ito
Shinro Tachibana
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO871574D0 publication Critical patent/NO871574D0/no
Publication of NO871574L publication Critical patent/NO871574L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/17—Vasoactive intestinal peptides; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO871574A 1986-04-17 1987-04-14 Fremgangsmaate for fremstilling av terapeutisk aktive peptider. NO871574L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61086987A JPS62246595A (ja) 1986-04-17 1986-04-17 気菅支拡張作用・降圧作用ペプタイド

Publications (2)

Publication Number Publication Date
NO871574D0 true NO871574D0 (no) 1987-04-14
NO871574L NO871574L (no) 1987-10-19

Family

ID=13902213

Family Applications (1)

Application Number Title Priority Date Filing Date
NO871574A NO871574L (no) 1986-04-17 1987-04-14 Fremgangsmaate for fremstilling av terapeutisk aktive peptider.

Country Status (10)

Country Link
US (2) US4757133A (no)
EP (1) EP0241926B1 (no)
JP (1) JPS62246595A (no)
AT (1) ATE84048T1 (no)
CA (1) CA1288894C (no)
DE (1) DE3783257T2 (no)
DK (1) DK193887A (no)
ES (1) ES2052507T3 (no)
GR (1) GR3006718T3 (no)
NO (1) NO871574L (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939224A (en) * 1987-02-26 1990-07-03 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
SE8702520D0 (sv) * 1987-06-16 1987-06-16 Kabigen Ab Mammal intestine hormone precursor
IL87055A (en) * 1988-07-08 1994-06-24 Illana Gozes Conjugates of vasoactive intestinal peptide (vip) and of fragments thereof and pharmaceutical compositions comprising them
US5128242A (en) * 1989-06-19 1992-07-07 The Administrators Of The Tulane Educational Fund Hypothalamic polypeptides with adenylate cyclase stimulating activity
US5234907A (en) * 1989-06-30 1993-08-10 Hoffmann-La Roche Inc. Synthetic vasoactive intestinal peptide analogs
US5141924A (en) * 1989-06-30 1992-08-25 Hoffmann-La Roche, Inc. Synthetic vasoactive intestinal peptide analogs
US5236904A (en) * 1989-09-18 1993-08-17 Senetek, Plc Erection-inducing methods and compositions
US5447912A (en) * 1989-09-18 1995-09-05 Senetek, Plc Erection-inducing methods and compositions
JPH04193896A (ja) * 1989-10-26 1992-07-13 Meiji Seika Kaisha Ltd 活性ペプチド
JPH03181499A (ja) * 1989-12-11 1991-08-07 Akira Kaji 新規ペプチド
EP0463450B1 (en) * 1990-06-26 1994-02-16 Sanwa Kagaku Kenkyusho Co., Ltd. Vasoactive intestinal polypeptide analogues and use thereof
JPH05238950A (ja) * 1991-04-22 1993-09-17 Sanwa Kagaku Kenkyusho Co Ltd 易吸収性ｖｉｐ製剤
US5958881A (en) * 1991-04-25 1999-09-28 Korman; Louis Y. Composition containing VIP for injection and a method of enhancing visualization of tissues during medical procedures
US5623050A (en) * 1991-08-22 1997-04-22 Takeda Chemical Industries, Ltd. Stable polypeptides having c-AMP production enhancing activity and the use thereof
US5998368A (en) * 1991-10-31 1999-12-07 Yeda Research And Development Co. Ltd. Derivatives of structurally modified VIP and pharmaceutical compositions containing them
US5681816A (en) * 1992-04-24 1997-10-28 Korman; Louis Y. Method of inducing temporary paralysis of the gastrointestinal tract during medical procedure
US5252747A (en) * 1992-09-11 1993-10-12 Abbott Laboratories Chiral quinolone intermediates
AU682638B2 (en) * 1995-06-09 1997-10-09 ILS, Inc. Peptide, bronchodilator and blood flow ameliorant
US7332473B2 (en) 2002-11-27 2008-02-19 Itoham Foods Inc. Peptides and medicinal compositions containing the same
US20090170775A1 (en) * 2004-10-08 2009-07-02 Transition Therapeutics, Inc. Vasoactive intestinal polypeptide compositions
US20080214440A1 (en) * 2004-10-08 2008-09-04 Forbes Medi-Tech (Research), Inc. Vasoactive intestinal polypeptide compositions
US20070293429A1 (en) * 2004-10-08 2007-12-20 Therapei Pharmaceuticals, Inc. Vasoactive Intestinal Polypeptide Compositions
AU2005294125A1 (en) * 2004-10-08 2006-04-20 Transition Therapeutics Inc. Vasoactive intestinal polypeptide pharmaceuticals
US7595294B2 (en) * 2004-10-08 2009-09-29 Transition Therapeutics, Inc. Vasoactive intestinal polypeptide pharmaceuticals
EP2041168A2 (en) * 2006-07-06 2009-04-01 F.Hoffmann-La Roche Ag Novel analogs of vasoactive intestinal peptide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3880826A (en) * 1971-09-17 1975-04-29 Sami I Said Vasoactive intestinal peptide
US3862927A (en) * 1973-02-26 1975-01-28 Sami I Said Process for preparation of vasoactive intestinal peptide
US4016258A (en) * 1975-08-05 1977-04-05 Said Sami I Vasoactive intestinal peptide from fowl
US4605641A (en) * 1984-10-09 1986-08-12 Hoffmann-La Roche Inc. Synthetic vasoactive intestinal peptide analogs

Also Published As

Publication number Publication date
DK193887A (da) 1987-10-18
EP0241926A3 (en) 1989-03-08
CA1288894C (en) 1991-09-10
EP0241926A2 (en) 1987-10-21
EP0241926B1 (en) 1992-12-30
NO871574L (no) 1987-10-19
JPS62246595A (ja) 1987-10-27
DE3783257D1 (de) 1993-02-11
ATE84048T1 (de) 1993-01-15
GR3006718T3 (no) 1993-06-30
DE3783257T2 (de) 1993-05-13
ES2052507T3 (es) 1994-07-16
DK193887D0 (da) 1987-04-14
US4822774A (en) 1989-04-18
US4757133A (en) 1988-07-12

Similar Documents

Publication Publication Date Title
NO871574D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive peptider.
CA2024651A1 (en) High-absorbable transvaginal preparation containing biologically active polypeptide
BR9507811B1 (pt) polipeptìdeos e composição farmacêutica.
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
DE3875108D1 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
CA2189947A1 (en) Use of von willebrand factor and pharmaceutical formulation
IT8619055A0 (it) Composizioni farmaceutiche comprendenti peptidi del gruppo colecistochinina-cerulina per il trattamento terapeutico degli statidi shock e dell'insufficienza respiratoria e cardiocircolatoria.
CA2025070A1 (en) Recombinant aprotinin variants genetically engineered process for the microbial preparation of homgeneously processed aprotinin variants and the therapeutic use thereof
AU682638B2 (en) Peptide, bronchodilator and blood flow ameliorant
NO177859C (no) Fremgangsmåte til produksjon av angiogen faktor
EP0328089A3 (en) Reduced size lhrh analogs
AU7831887A (en) Pharmaceutical composition of a short, glycine and tyrosine containing peptide
ATE260672T1 (de) Pharmazeutische lysin enthaltende polypeptid- zusammensetzungen und verfahren zu deren verwendung
JPS649938A (en) Oral ingestive composition
NO171728C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 4'-demetylepipodofyllotoksin-glukosider
KR950704358A (ko) 카텝신 l 특이적 저해 폴리펩티드
CA2036592A1 (en) Therapeutic agent for diabetic gangrene
GB2180746B (en) Compositions for administering biologically active peptides via mucous membranes
EP0154544A3 (en) Des-proline vasopressin antagonists
RU94037232A (ru) Пептиды с органозащитной активностью, способ их получения и их применение
EP0342015A3 (en) Peptides, their use and pharmaceutical compositions containing them
EP0261088A3 (en) Process for the production of heparanlysopeptide sulphate, the product thus obtained and its therapeutic use
SE9003040D0 (sv) Analogues of cyclolinopeptide a and the use thereof